Abstract: Disclosed herein are an apparatus for writing a motion script and an apparatus and method for self-teaching of a motion. The method for self-teaching of a motion, in which the apparatus for writing a motion script and the apparatus for self-teaching of a motion are used, includes creating, by the apparatus for writing a motion script, a motion script based on expert motion of a first user; analyzing, by the apparatus for self-teaching of a motion, a motion of a second user, who learns the expert motion, based on the motion script; and outputting, by the apparatus for self-teaching of a motion, a result of analysis of the motion of the second user.

Abstract: A subject support apparatus includes an upper portion and a lower portion. The upper portion includes a vest having a first end and a second end, a closure mechanism configured to couple the first end of the vest to the second end of the vest from a bottom end of the vest to a top end of the vest to form a closed loop, and a pair of shoulder straps extending from the vest. The lower portion includes a seat piece having a first end and a second end, and a pair of loop straps extending from the first end and the second end of the seat piece. Subject support systems including the subject support apparatus and methods of lifting a subject using the subject support apparatus are also described.

Abstract: Disclosed herein is an immersive video formatting method and apparatus for supporting motion parallax, The immersive video formatting method includes acquiring a basic video at a basic position, acquiring a multiple view video at at least one position different from the basic position, acquiring at least one residual video plus depth (RVD) video using the basic video and the multiple view video, and generating at least one of a packed video plus depth (PVD) video or predetermined metadata using the acquired basic video and the at least one RVD video.

Abstract: An operation method of a terminal for reducing power consumption may comprise receiving, by a physical layer of the terminal, a wake-up signal (WUS) from a base station; notifying, by the physical layer of the terminal, the reception of the WUS to a medium access control (MAC) layer of the terminal; performing, by the physical layer of the terminal, a downlink physical layer monitoring operation for a preconfigured time period from a time point of the reception of the WUS; and when the preconfigured time period expires, the physical layer of the terminal stops the downlink physical layer monitoring operation.

Abstract: The present invention relates to a method for regenerating an acid gas absorbent using Ag2O and Ag2CO3 mixed catalyst in an acid gas absorbent regeneration process in an acid gas capture process using an amine absorbent absorbing acid gas. Regeneration method of carbon dioxide absorbent using Ag2O and Ag2CO3 mixed catalyst of the present invention promotes the decomposition of carbon dioxide-bound carbamate from the carbon dioxide-absorbed absorbent of Ag2O and Ag2CO3 mixed catalysts through a novel catalytic reaction pathway to remove efficiently.

Abstract: The present application relates to compounds of Formula I (I) or pharmaceutically acceptable salts, solvates and/or prodrugs thereof, to compositions comprising these compounds or pharmaceutically acceptable salts, solvates and/or prodrugs thereof, and various uses in the treatment of diseases, disorders or conditions that are treatable by inhibiting interactions with BCL6 BTB, such as cancer.

Abstract: The present specification discloses modified anti-PD-L1 antibodies that abolishes Fc-related effector function and enhances clearance rate while maintaining therapeutic efficacy for neurodegenerative disease modification. The present specification also discloses nucleic acid sequences and expression constructs encoding such modified anti-PD-L1 antibodies as well as methods of making such modified anti-PD-L1 antibodies. In addition, the present specification discloses methods of treatment and uses that employ an administration regime of the disclosed anti-PD-L1 antibodies that ensures the antibodies are present for only a specific period of time and then are sufficiently cleared from the body to ensure treatment efficacy is maintained.

Abstract: A microchannel-membrane device comprises a microchannel extending through at least one electrode, the microchannel having a predetermined depth; an ionic permselective medium, such as a membrane, across the microchannel between the electrodes; and a heater, or array of heaters, embedded below the microchannel on at least one side of the permselective membrane. The heaters can be either prefabricated or dynamically patterned using laser illumination with/without photoconductive coating. The heaters are on the depletion side of the membrane and induce a vortex which limits the growth of the diffusion area. Operation of the heaters allows for controlled positioning of the end of the diffusion area and with it also the position of the preconcentrated molecule plug.

Abstract: A polymeric compound is disclosed herein, having the general formula I: wherein m, n, X, Y, Z and L are as defined herein. Further disclosed herein are lipid bilayers comprising at least one bilayer-forming lipid and the aforementioned polymeric compound, and liposomes comprising such a bilayer, as well as methods, uses and compositions utilizing such bilayers and/or liposomes for reducing a friction coefficient of a surface and/or for inhibiting biofilm formation.

Abstract: A radiation detector for detecting radiation and identifying the type thereof includes: a scintillator module formed by stacking a first scintillator emitting light in a first wavelength range by reacting with first radiation and a second scintillator emitting light in a second wavelength range by reacting with second radiation; a first optical filter attached to a region of the scintillator module and transmitting the light in the first wavelength range; a second optical filter attached to another region of the scintillator module and transmitting the light in the second wavelength range; a first photodetector sensing the light in the first wavelength range that has passed through the first optical filter; a second photodetector sensing the light in the second wavelength range that has passed through the second optical filter; and a controller determining radiation on the basis of sensing results by the first photodetector and the second photodetector.

Abstract: Cell-based compositions and methods for targeting and treating human diseases, including cancers and infectious diseases, are provided, wherein exogenous intracellular sarcosine is used for improved delivery of the composition.

Abstract: Disclosed is a method of decoding an image and a method of encoding an image. The method of decoding an image includes: obtaining motion-constrained tile set information; determining, on the basis of the motion-constrained tile set information, a first boundary region of a collocated tile set within a reference picture, which corresponds to a motion-constrained tile set; padding a second boundary region corresponding to the first boundary region; and performing inter prediction on the motion-constrained tile set by using a collocated tile set that includes the padded second boundary region.

Abstract: The present disclosure provides compositions and methods for renal therapy. In various aspects, the present disclosure provides a composition comprising a knotted peptide, wherein upon administration to a subject the knotted peptide homes, targets, is directed to, accumulates in, migrates to, is retained by, and/or binds to renal tissue of the subject. In various aspects, the composition further comprises an active agent coupled to the knotted peptide. The composition, when administered to the subject, may induce protective preconditioning or acquired cytoresistance.

Abstract: The present application provides detectable compounds useful for identifying compounds that bind (e.g., inhibit) MmpL3. Methods of identifying compounds that bind and/or inhibit MmpL3 are also provided.

Abstract: This document relates to methods and materials for improving artificial cardiac pacing and/or resynchronization. For example, this document relates to methods and devices for artificial cardiac pacing and/or resynchronization by stimulating the His bundle.

Abstract: A waveguide has a first conductor surface facing toward the interior of the waveguide, a second conductor surface facing toward the interior of the waveguide, and a slot extending from the first conductor surface to the outside of the waveguide. The first conductor surface and the second conductor surface electrically communicate with each other and face each other. The first length in the y direction of the first conductor surface in a cross section perpendicular to the z direction is smaller than the second length in the y direction of the second conductor surface in the cross section perpendicular to the z direction. The first length includes the length in the y direction of the slot in the cross section perpendicular to the z direction. The second length is smaller than the distance between the first conductor surface and the second conductor surface in the x direction.

Abstract: A device and method for manufacturing a two-dimensional electrostrictive field effect transistor having a substrate, a source, a drain, and a channel disposed between the source and the drain. The channel is a two-dimensional layered material and a gate proximate the channel. The gate has a column of an electrostrictive or piezoelectric or ferroelectric material, wherein an electrical input to the gate produces an elongation of the column that applies a force or mechanical stress on the channel and reduces a bandgap of two-dimensional material such that the two-dimensional electrostrictive field effect transistor operates with a subthreshold slope that is less than 60 mV/decade.

Abstract: The present disclosure relates to novel non-metallic ignition devices, and the method of making and using the novel non-metallic ignition devices.

Abstract: The present invention relates to hemagglutinin-specific antibodies, fragments thereof, and uses thereof. More specifically, these antibodies and fragments thereof are able to recognize antigen from multiple influenza strains.

Abstract: Disclosed herein is a chemo-proteomic probe for labelling and monitoring a live microbe interacting with a host cell and for qualitative and quantitative analyses of those proteins involved during a microbe infects the host cell. This probe comprises a functional group for conjugating to a surface protein of a live microbe under a physiological condition; a photo-reactive group for covalent cross-linking to an interacting cell protein of a host; and a tag for isolating the cross-linked complex of the surface protein of said live microbe and the interacting protein of a host cell for qualitative and quantitative proteomics analyses. The probe may further comprise a visualization tag. This technology takes advantage of the high throughput feature of mass spectrometry analysis and combines it with a uniquely designed chemistry to achieve high efficient isolation and analysis of host cell proteins interacting with a pathogen at different stages of an infection.